Immunodeficient NBSGW mouse strain allows chemotherapy modeling in AML patient-derived xenografts. (2024)

First Author: Dembitz V
Attributed to:  Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/hem3.28

PubMed Identifier: 38434525

Publication URI: http://europepmc.org/abstract/MED/38434525

Type: Journal Article/Review

Volume: 8

Parent Publication: HemaSphere

Issue: 1

ISSN: 2572-9241